Skip to main content

Advertisement

Log in

Spectral domain OCT can differentiate the retinal morphological changes of patients with Parkinson’s disease in clinical middle stages

  • Brief Communication
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Background

The retinal morphological change has been detected in Parkinson’s disease. However, the previous studies had a controversial conclusion. The aim of this study was to observe the changes of retinal morphology in patients with Parkinson’s disease with different clinical stages based on Hoehn-Yahr stage by spectral domain optical coherence tomography (SD-OCT).

Method

Fifty-three PD patients and forty-one healthy controls (HC) were enrolled. Subjects were assessed for the retinal structure using SD-OCT and general ophthalmic examinations. The PD group was divided into three subgroups by the Hoehn and Yahr scale: H-Y I stage group, H-Y II stage group, and H-Y III stage group.

Results

The mean deviation of visual field had a significant difference among the four groups. The macular retinal thickness (MRT) and macular volume (MV) were obviously decreased in PD patients. And the further statistical analysis showed that the difference appeared between the H-Y III stage group and HC group. The other subgroups had no differences compared with the HC group.

Conclusion

SD-OCT examination can detect the changes in retinal morphology in PD patients, and it may not be found the difference until the patients are in the H-Y III stage (the middle stage of PD).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. de Lau LM, Breteler MM (2006) Epidemiology of Parkinson’s disease. Lancet Neurol 5(6):525–535. https://doi.org/10.1016/S1474-4422(06)70471-9

    Article  PubMed  Google Scholar 

  2. Bodiswollner I, Kozlowski P, Glazman S, Miri S (2014) α-Synuclein in the inner retina in parkinson disease. Ann Neurol 75(6):964–966

    Article  CAS  Google Scholar 

  3. Satue M, Seral M, Otin S, Alarcia R, Herrero R, Bambo MP, Fuertes MI, Pablo LE, Garcia-Martin E (2014) Retinal thinning and correlation with functional disability in patients with Parkinson’s disease. Br J Ophthalmol 98(3):350–355. https://doi.org/10.1136/bjophthalmol-2013-304152

    Article  CAS  PubMed  Google Scholar 

  4. Huang J, Li Y, Xiao J, Zhang Q, Xu G, Wu G, Liu T, Luo W (2018) Combination of multifocal electroretinogram and spectral-domain OCT can increase diagnostic efficacy of Parkinson’s disease. J Park Dis 2018:1–7

    Google Scholar 

  5. Sari ES, Koc R, Yazici A, Sahin G, Ermis SS (2014) Ganglion cell-inner plexiform layer thickness in patients with Parkinson disease and association with disease severity and duration. J Neuroophthalmol 35(2):117

    Google Scholar 

  6. Lee J, Kim JM, Ahn J, Kim H, Jeon BS, Kim TW (2014) Retinal nerve fiber layer thickness and visual hallucinations in Parkinson’s disease. Mov Disord 29(1):61–67. https://doi.org/10.1002/mds.25543

    Article  PubMed  Google Scholar 

  7. Tsironi EE, Dastiridou A, Katsanos A, Dardiotis E, Veliki S, Patramani G, Zacharaki F, Ralli S, Hadjigeorgiou GM (2012) Perimetric and retinal nerve fiber layer findings in patients with Parkinson’s disease. BMC Ophthalmol 12(1):54–54

    Article  PubMed  PubMed Central  Google Scholar 

  8. Unlu M, Sevim DG, Gultekin M, Karaca C (2018) Correlations among multifocal electroretinography and optical coherence tomography findings in patients with Parkinson’s disease. Neurol Sci 39(3):533–541

    Article  PubMed  Google Scholar 

  9. Garciamartin E, Larrosa JM, Polo V, Satue M, Marques ML, Alarcia R, Seral M, Fuertes I, Otin S, Pablo LE (2014) Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration. Am J Ophthalmol 157(2):470–478

    Article  Google Scholar 

  10. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors are grateful to the patients with Parkinson’s disease and the healthy people enrolled for their participation in this research.

Funding

This work was supported by the Suzhou Science and Technology Development Project (SYSD2016091), National Natural Science Foundation of China (No. 81671270), Project of Clinical Advantage Scientific Group of the Second Affiliated Hospital of Soochow University (XKQ2015002), and the Nature Science Foundation of Jiangsu Province (BK20161220).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Weifeng Luo.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, J., Wang, Q., Li, K. et al. Spectral domain OCT can differentiate the retinal morphological changes of patients with Parkinson’s disease in clinical middle stages. Neurol Sci 41, 1909–1912 (2020). https://doi.org/10.1007/s10072-020-04266-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-020-04266-z

Keywords

Navigation